| P2093 | author name string | Hak E | |
| | de Melker RA | |
| | Stalman W | |
| | van Essen GA | |
| | Buskens E | |
| P2860 | cites work | Influenza vaccination in 18 developed countries, 1980-1992. | Q30464520 |
| | Clinical effectiveness of influenza vaccination in Manitoba | Q30467421 |
| | Review of cost-benefit analyses of influenza vaccine | Q33560354 |
| | Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? | Q34054800 |
| | Subunit influenza vaccination in adults with asthma: effect on clinical state, airway reactivity, and antibody response | Q34070097 |
| | Population-based prevention of influenza in Dutch general practice | Q34214706 |
| | Use of influenza vaccine in The Netherlands | Q35180661 |
| | What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice | Q35188175 |
| | Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial | Q35190152 |
| | Viral respiratory tract infection and exacerbations of asthma in adult patients | Q36187997 |
| | Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database | Q36504369 |
| | The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. | Q40474960 |
| | Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines | Q40643324 |
| | Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial | Q40666042 |
| | Influenza and asthma | Q44072722 |
| | Influenza and ischaemic heart disease--a possible trigger for acute myocardial infarction? | Q44591929 |
| | Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization | Q45260225 |
| | Respiratory syncytial virus or influenza? | Q45783418 |
| | Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus | Q45829838 |
| | Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. | Q50595642 |
| | The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. | Q50602332 |
| | Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons | Q57109900 |
| | Influenza vaccination | Q70434847 |
| | [Influenza in the 1995/'96 season; vaccine composition for the 1996/'97 season] | Q71891089 |
| | Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease | Q72205122 |
| | Influenza immunization policies in Europe and the United States | Q72339923 |
| | The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial | Q72821242 |
| | The impact and cost of influenza in the elderly | Q72939398 |
| P433 | issue | 2 | |
| P921 | main subject | Netherlands | Q55 |
| | lung disease | Q3392853 |
| P304 | page(s) | 120-125 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Journal of Epidemiology and Community Health | Q3428712 |
| P1476 | title | Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands | |
| P478 | volume | 52 | |